| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 63.2334 | 66 |
| GSM780708 | Untreated after 4 days (C2_1) | 56.8608 | 62 |
| GSM780709 | Untreated after 4 days (C3_1) | 46.7545 | 36 |
| GSM780719 | Untreated after 4 days (C1_2) | 67.2632 | 68 |
| GSM780720 | Untreated after 4 days (C2_2) | 61.3531 | 65 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.8374 | 40 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 80.4472 | 72 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.5756 | 35 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 119.033 | 78 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 83.0186 | 72 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 53.3007 | 57 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 115.027 | 77 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.6729 | 50 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 66.9116 | 68 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 61.6227 | 65 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.2325 | 33 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 64.7917 | 67 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 54.8763 | 59 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 55.3166 | 60 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.9175 | 51 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 64.275 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 53.1113 | 56 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 74.4414 | 70 |